Table 1 Sociodemographic characteristics of the participants (N = 155)
Variable | N (%) |
|---|---|
Gender | |
Male | 101 (65.2%) |
Female | 54 (34.8%) |
Marital status | |
Single/divorced/widowed | 22 (14.2%) |
Married | 133 (85.8%) |
Education level | |
Illiterate | 18 (11.7%) |
Primary | 39 (25.3%) |
Complementary | 49 (31.8%) |
Secondary | 33 (21.4%) |
University | 15 (9.7%) |
Infected by the coronavirus | |
No | 33 (21.3%) |
Yes | 122 (78.7%) |
Family history of psychiatric diseases | |
No | 94 (60.6%) |
Yes | 61 (39.4%) |
Mean ± SD | |
Age (in years) | 56.68 ± 10.47 |
Chlorpromazine equivalent dose (mg) | 1189.81 ± 2299.35 |
Cognitive function (MOCA score) | 13.94 ± 6.43 |
PANSS positive score | 16.88 ± 7.18 |
Depression | 10.69 ± 6.41 |
Anxiety | 14.48 ± 8.77 |
Distress | 9.79 ± 6.91 |
Insomnia | 36.16 ± 15.09 |
Fear of COVID-19 | 18.34 ± 6.45 |
Lifetime traumatic experiences | 38.59 ± 15.54 |